2-methylcitric acid has been researched along with Carcinoma, Hepatocellular in 1 studies
2-methylcitric acid: RN given refers to parent cpd
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, J | 3 |
| Ding, J | 3 |
| Shen, Q | 3 |
| Wang, X | 3 |
| Wang, M | 3 |
| Huang, Y | 3 |
| Zhang, X | 3 |
| Zhu, H | 3 |
| Zhang, F | 3 |
| Wu, D | 3 |
| Peng, M | 3 |
| Zhang, Z | 3 |
| Yuan, Y | 3 |
| Li, W | 3 |
| She, ZG | 3 |
| Zhang, XJ | 3 |
| Li, H | 3 |
| Zhang, P | 3 |
| Huang, Z | 3 |
1 other study available for 2-methylcitric acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |